Literature DB >> 28629790

Current therapeutic approaches for HBV infected patients.

Upkar S Gill1, Patrick T F Kennedy2.   

Abstract

Entities:  

Keywords:  Hepatitis B surface antigen; Novel therapeutic agents; Nucleos(t)ide analogues; Pegylated interferon; cccDNA

Mesh：

Substances：

Year:  2017        PMID： 28629790     DOI： 10.1016/j.jhep.2017.04.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  MHC-E-Restricted CD8+ T Cells Target Hepatitis B Virus-Infected Human Hepatocytes.

Authors:  Benjamin J Burwitz; Patrick K Hashiguchi; Mandana Mansouri; Christine Meyer; Roxanne M Gilbride; Sreya Biswas; Jennie L Womack; Jason S Reed; Helen L Wu; Michael K Axthelm; Scott G Hansen; Louis J Picker; Klaus Früh; Jonah B Sacha
Journal:  J Immunol       Date:  2020-03-11       Impact factor: 5.422

2.  Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.

Authors:  Ni Lin; Aizhu Ye; Jinpiao Lin; Can Liu; Jinlan Huang; Ya Fu; Songhang Wu; Siyi Xu; Long Wang; Qishui Ou
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

3.  Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity.

Authors:  Sreya Biswas; Lauren N Rust; Jochen M Wettengel; Sofiya Yusova; Miranda Fischer; Julien N Carson; Josie Johnson; Lei Wei; Trason Thode; Mohan R Kaadige; Sunil Sharma; Majd Agbaria; Benjamin N Bimber; Thomas Tu; Ulrike Protzer; Alexander Ploss; Jeremy V Smedley; Gershon Golomb; Jonah B Sacha; Benjamin J Burwitz
Journal:  Nat Commun       Date:  2022-05-30       Impact factor: 17.694

Review 4.  Liver sampling: a vital window into HBV pathogenesis on the path to functional cure.

Authors:  Upkar S Gill; Laura J Pallett; Patrick T F Kennedy; Mala K Maini
Journal:  Gut       Date:  2018-01-13       Impact factor: 23.059

5.  Barriers to chronic Hepatitis B treatment and care in Ghana: A qualitative study with people with Hepatitis B and healthcare providers.

Authors:  Charles Ampong Adjei; Sarah E Stutterheim; Florence Naab; Robert A C Ruiter
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.